Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
B. Hofbauer, I. Leitner & N. S. Ryder. (2002) In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin. Medical Mycology 40:2, pages 179-183.
Read now
Read now
Articles from other publishers (7)
A. Shemer, N. Sakka, R. Baran, R. Scher, B. Amichai, L. Norman, R. Farhi, R. Magun, A. Brazilai & R. Daniel. (2015) Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails. Journal of the European Academy of Dermatology and Venereology 29:3, pages 521-526.
Crossref
Crossref
H.R. Ashbee & M.H. Gilleece. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
879
900
.
. 2011. British Association of Dermatologists' Management Guidelines. British Association of Dermatologists' Management Guidelines
91
117
.
S. W. Chapman, P. Pappas, C. Kauffmann, E. B. Smith, R. Dietze, N. Tiraboschi-Foss, A. Restrepo, A. B. Bustamante, C. Opper, S. Emady-Azar & R. Bakshi. (2004) Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day-1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Vergleichende Bewertung der Wirksamkeit und Sicherheit zweier Terbinafin-Dosierungen (500 und 1000 mg/Tag) in der Therapie der kutanen und lymphokutanen Sporotrichose. Mycoses 47:1-2, pages 62-68.
Crossref
Crossref
D.T. Roberts, W.D. Taylor & J. Boyle. (2003) Guidelines for treatment of onychomycosis. British Journal of Dermatology 148:3, pages 402-410.
Crossref
Crossref
Malcolm J.M. Darkes, Lesley J. Scott & Karen L. Goa. (2003) Terbinafine. American Journal of Clinical Dermatology 4:1, pages 39-65.
Crossref
Crossref
Hay. (1999) Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. British Journal of Dermatology 141:s56, pages 36-40.
Crossref
Crossref